Champions Oncology (CSBR) Posts Narrower Q1 Loss

September 9, 2016 8:21 AM EDT

Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of ($0.15), versus ($0.24) reported last year. Revenue for the quarter came in at $3.7 million, versus $2.8 million reported last year.

Reaffirms FY17 outlook.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings